Immix Biopharma, Inc.IMMXNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank80
3Y CAGR+86.3%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+86.3%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
6.5x
Strong expansion
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20244.70-35.8%
20237.31+202.7%
20222.42+232.5%
20210.73+112.1%
2020-6.03-77.5%
2019-3.40-